Literature DB >> 21970972

Neuroprotective effect of silibinin in diabetic mice.

Giuseppina Marrazzo1, Paolo Bosco, Francesco La Delia, Giovanni Scapagnini, Claudia Di Giacomo, Michele Malaguarnera, Fabio Galvano, Anna Nicolosi, Giovanni Li Volti.   

Abstract

Diabetes mellitus is associated with a higher oxidative stress and reduced activity of the antioxidant defense system in different brain regions. Results from numerous studies reported impaired cognitive and neurochemical function in diabetic patients and streptozotocin induced diabetic rodents. It is well established that polyphenols exert potent antioxidant and protective functions. Based on recent findings, one potential target for the antioxidant/antinflammatory properties of polyphenols is the heme oxygenase (HO)-1 pathway. Among various compounds tested silibinin, the main component of silymarin, has been shown to possess a strong antioxidant effect in various experimental models; however a study on the possible neuroprotective effect of this compound on the brain of diabetic animals is currently lacking. Therefore, we studied and measured in lean mice (db/m) and knock out mice for the leptin receptors mice (db/db) the effect of silibinin on HO-1 protein levels, non proteic thiol groups, isoprostanes and 8-OH deoxyguanosine (markers of lipid peroxidation and DNA damage, respectively) in different brain regions. Our results showed that HO-1 is differently expressed in various brain regions in db/db mice when compared to lean animals. Furthermore, silibinin provides DNA protection and reduces oxidative stress in a brain specific area, in part via the activation of the HO system. Silibinin may provide a valid tool to counteract oxidative stress in the diabetic status in the central nervous system under diabetic condition.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21970972     DOI: 10.1016/j.neulet.2011.09.041

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  23 in total

1.  Silibinin induced the apoptosis of Hep-2 cells via oxidative stress and down-regulating survivin expression.

Authors:  Xinxin Yang; Xiaoyu Li; Liangxiang An; Bo Bai; Jing Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-12       Impact factor: 2.503

2.  Silybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin.

Authors:  Michele Malaguarnera; Massimo Motta; Marco Vacante; Giulia Malaguarnera; Filippo Caraci; Giuseppe Nunnari; Caterina Gagliano; Carmela Greco; Giuseppe Chisari; Filippo Drago; Gaetano Bertino
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

Review 3.  Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain.

Authors:  D Allan Butterfield; Fabio Di Domenico; Eugenio Barone
Journal:  Biochim Biophys Acta       Date:  2014-06-17

4.  Increased oxidative stress and imbalance in antioxidant enzymes in the brains of alloxan-induced diabetic rats.

Authors:  Luciane B Ceretta; Gislaine Z Réus; Helena M Abelaira; Karine F Ribeiro; Giovanni Zappellini; Francine F Felisbino; Amanda V Steckert; Felipe Dal-Pizzol; João Quevedo
Journal:  Exp Diabetes Res       Date:  2012-05-08

5.  Olive Leaf Extract from Sicilian Cultivar Reduced Lipid Accumulation by Inducing Thermogenic Pathway during Adipogenesis.

Authors:  Rosa Palmeri; Julieta I Monteleone; Giovanni Spagna; Cristina Restuccia; Marco Raffaele; Luca Vanella; Giovanni Li Volti; Ignazio Barbagallo
Journal:  Front Pharmacol       Date:  2016-05-31       Impact factor: 5.810

6.  Effect of Treatment with Cyanidin-3-O-β-D-Glucoside on Rat Ischemic/Reperfusion Brain Damage.

Authors:  Claudia Di Giacomo; Rosaria Acquaviva; Rosa Santangelo; Valeria Sorrenti; Luca Vanella; Giovanni Li Volti; Nicolantonio D'Orazio; Angelo Vanella; Fabio Galvano
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-13       Impact factor: 2.629

7.  Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy.

Authors:  Claudio Bucolo; Giuseppina Marrazzo; Chiara Bianca Maria Platania; Filippo Drago; Gian Marco Leggio; Salvatore Salomone
Journal:  J Diabetes Res       Date:  2013-05-23       Impact factor: 4.011

8.  Silymarin effect on amyloid-β plaque accumulation and gene expression of APP in an Alzheimer's disease rat model.

Authors:  Parichehreh Yaghmaei; Katia Azarfar; Mehrooz Dezfulian; Azadeh Ebrahim-Habibi
Journal:  Daru       Date:  2014-01-24       Impact factor: 3.117

9.  Silibinin inhibits ICAM-1 expression via regulation of N-linked and O-linked glycosylation in ARPE-19 cells.

Authors:  Yi-Hao Chen; Ching-Long Chen; Chang-Min Liang; Jy-Been Liang; Ming-Cheng Tai; Yun-Hsiang Chang; Da-Wen Lu; Jiann-Torng Chen
Journal:  Biomed Res Int       Date:  2014-06-17       Impact factor: 3.411

10.  Homocysteine serum levels in diabetic patients with non proliferative, proliferative and without retinopathy.

Authors:  Giulia Malaguarnera; Caterina Gagliano; Maria Giordano; Salvatore Salomone; Marco Vacante; Claudio Bucolo; Filippo Caraci; Michele Reibaldi; Filippo Drago; Teresio Avitabile; Massimo Motta
Journal:  Biomed Res Int       Date:  2014-04-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.